Selection of blockbuster announcements

1、$BABA-SW (09988.HK) $Revenue in the fourth quarter was 204.05 billion yuan, up 9% from the same period last year

BABA announced results for the quarter ended March 31, 2022 (corresponding to the fourth quarter of fiscal year 2022). Total revenue was 204.05 billion yuan, up 9% year-on-year; cloud business revenue was 18.97 billion yuan, up 12% year-on-year; income from the local living services division increased 29% year-on-year to 10.445 billion yuan; adjusted net profit was 19.799 billion yuan, down 24% from the same period last year Adjusted income per ADS is 7.95 yuan, compared with 10.32 yuan in the same period last year.

2、$Baidu-SW (09888.HK) $Q1 revenue of 28.411 billion yuan, an increase of 1% over the same period last year

Baidu, Inc. 's Q1 revenue was 28.411 billion yuan, up 1% from the same period last year; the adjusted net profit was 3.879 billion yuan, compared with 4.297 billion yuan in the same period last year; and the adjusted profit per ADS was 11.22 yuan. In March, Baidu, Inc. App's MAU grew 13 per cent year-on-year to 632 million, and the number of daily login users reached 83 per cent.

3、$JD Logistics, Inc. (02618.HK) $Completed the issuance of 261 million shares to JD.com Science and Technology Group, raising a net fund of 4.411 billion yuan

JD Logistics, Inc. announced that on March 25, 2022, the Company entered into the subscription Agreement with the substantial shareholder Jingdong Technology Group Corporation, whereby Jingdong Technology Group Corporation conditionally agreed to subscribe and the Company conditionally agreed to allot and issue 261.4 million subscription shares at a subscription price of HK $20.71 per subscription share (equivalent to a total subscription amount of approximately US $692 million or approximately RMB 4.411 billion). All the prerequisites for the subscription set out in the subscription Agreement have been met. As a result, the subscription was completed on 26 May 2022.

4、$Baozun Inc-SW (09991.HK) $The total net income in the first quarter was 1.984 billion yuan, a year-on-year decrease of 1.8%

Baozun Inc-SW announced that in the first quarter of 2022, the total transaction volume (GMV) was 16.998 billion yuan, an annual increase of 28.4 percent, and total net revenue was 1.984 billion yuan, a decrease of 1.8 percent. Of this total, service revenue was 1.303 billion yuan, an annual increase of 24.3%. The net loss attributable to the ordinary shareholders of Baozun Inc Co., Ltd. was RMB 122 million, while the net profit attributed to the ordinary shareholders of Baozun Inc Co., Ltd. was RMB 1.3 million in the same period last year. The net profit attributable to the common shareholders of Baozun Inc Co., Ltd. under non-GAAP was 1.2 million yuan, compared with 61.2 million yuan in the same period last year.

5、$Genscript Biotech Corporation (01548.HK) $CARVYKTI ™is approved by the European Commission

Genscript Biotech Corporation issued an announcement, Legend Biotech Corp, a non-wholly owned subsidiary of the company, announced that the European Commission had granted CARVYKTI ™(ciltacabtagene autoleucel, cilta-cel) conditional listing permission for at least three previous treatments, including immunomodulators, proteasome inhibitors and anti-CD38 antibodies. And the last treatment showed relapse or refractory multiple myeloma (R MM) adult patients with disease progression. Legend Biotech Corp and Janssen Biotech, Inc. ("Yang Sen") signed a global exclusive license and cooperation agreement in December 2017 to develop and commercialize Cedar Oren.

Financial data

BABA-SW (09988.HK) fourth quarter income of 204.05 billion yuan, up 9% from the same period last year.

The revenue of Baidu-SW (09888.HK) Q1 was 28.411 billion yuan, up 1% from the same period last year.

Baozun Inc-SW (09991) the total transaction volume (GMV) in the first quarter was 16.998 billion yuan, an annual increase of 28.4%.

Li's Pharmaceutical Co., Ltd. (00950): first-quarter net profit of HK $20.307 million fell 50.5% compared with the same period last year.

Increase and decrease holdings

Xiexin Technology (03800) main shareholder Zhu Family Trust spends about HK $67 million to increase its holdings of 24.944 million shares

Additional rights issue

JD Logistics, Inc. (02618) completed the issuance of 261 million shares to JD.com Technology Group, raising a net fund of 4.411 billion yuan.

Investment and operation

Jiayuan International Holdings (02768) intends to sell its 73.56% stake in Jiayuan Services and resume trading tomorrow

Genscript Biotech Corporation (01548): CARVYKTI ™approved by the European Commission

AVIC Engineering (02357): AVIC Electronics intends to absorb and merge AVIC Mechatronics

Fudan Zhangjiang (01349): plans to cooperate with Shanghai Handu on Parkinson's disease treatment drugs and sign relevant agreements

Minimally invasive robot-B (02252): R-ONE ®vascular interventional surgery robot to complete registration of clinical trials

China Xinlianxin Chemical Fertilizer (01866) plans to build a new chemical fertilizer and chemical material project.

Repurchase cancellation

AIA Group Limited (01299) spent HK $161 million to buy back 2.1 million shares on May 26th.

JD Health (06618) spent HK $25.822 million to buy back 554700 shares on May 26th.

Pop Mart International (09992) spent HK $14.999 million to buy back 526800 shares on May 26th.

Equity incentive

Eddie Palace (00286): the trustee may purchase 427.5 million shares or 1 million shares for the share incentive scheme